Hungary Richter CEO explains disappointing Q1 figures

Shares good news about dividend

Hungary's Richter performs below expectations in Q1

No new record in sales this quarter

Hungary Richter eyes bond issuance

Participation in central bank programme pending BoD approval

Hungary Richter sets new records - What next?

Record revenue in Q4 2020, as well

ANALYST VIEW - Erste sharply raises target price for Hungary's Richter

Share price climbs to new all-time high

Massive Richter turnover propels Budapest Stock Exchange

BUX did well in January 2021 even in international terms

European Commission reaches decision on Hungarian Richter's Esmya

It may be used in the EU only in certain cases

Hungary’s Richter completes contraceptive acquisition

Janssen’s transdermal patch to be sold outside the U.S.

Hungary Richter inks deal on drug sale in Latin America

Aims to become a global women's healthcare player

CHMP recommends restricting the use of Richter's Esmya

Ball now in European Commission's court

Hungary Richter stakeholder crosses north of 5% threshold

Orbán lists 11 successful Hungarian companies

Defends COVID-19 testing practices

Hungary to go on with COVID drug trial

Remdesivir research continues despite WHO statement

WHO finding is a cold shower: remdesivir has no substantial effect on COVID-19 patient's survival

Results of Solidarity trial leaked

Hungary Richter inks licence deal with Japan's Mochida

ANALYST VIEW - Drug of Hungary's Richter could be facing new rival

Jefferies publishes opinion

Wood takes the lead in Budapest bourse in August

Czech brokerage takes bigger bite of smaller pie

Hungarian state ownership in Richter decreases

Share transfer to foundation closed

ANALYST VIEW - Jefferies ups target price for Hungary's Richter

Share price close to all-time high

Richter receives marketing authorisation for Libdree in UK